EC Number   |
Application |
Reference |
|---|
   3.2.1.49 | biotechnology |
use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease |
707033 |
| 3.2.1.49 | diagnostics |
the enzyme is used for blood group conversion together with alpha-galactosidase, best in glucose buffer |
731531 |
| 3.2.1.49 | medicine |
alpha-N-acetylgalactosaminidase is an efficient enzyme for production of universal O blood cells |
750729 |
| 3.2.1.49 | medicine |
potential application in the field of erythrocyte conversion technology |
655755 |
| 3.2.1.49 | medicine |
the enzyme can be employed as a diagnostic/prognostic tool for patients with salivary gland adenocarcima |
655748 |
| 3.2.1.49 | medicine |
The enzyme is able to remove at neutral pH alpha-1,3-bound residues of N-acetylgalactosamine from glycoproteins of blood group A-substances and A-erythrocytes, converting them into 0 group substances |
-, 654777 |
| 3.2.1.49 | medicine |
the enzyme may be useful for enzymic conversion of type A2 to universally transfusable type O red blood cells, potential application in the field of solid organ transplantation |
655075 |
| 3.2.1.49 | medicine |
use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease |
707033 |
